Status:
ACTIVE_NOT_RECRUITING
Tele-Harm Reduction
Lead Sponsor:
University of Miami
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
IV Drug Usage
HIV Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test 2 different methods for offering medications that treat HIV, cure Hepatitis C Virus (HCV) (if applicable) and treat substance use disorder (if desired) to people w...
Eligibility Criteria
Inclusion
- age 18 or older
- able to speak English
- enrolled in IDEA Miami or IDEA Tampa SSPs
- injection drug use in past 12 months by self-report
- willing and able to sign informed consent, provide locator information and medical records release
- testing reactive for HIV by rapid test
- HIV RNA\>200 copies/ml as determined by on-site labs or abstracted medical records (result within 3 months of randomization date)
Exclusion
- testing HIV negative via rapid test
- receipt of THR intervention in the past 6 months
- inability to provide informed consent
- planning to leave the area within 12 months
- Principal or site investigator discretion
- currently in prison or jail
- Enrollment in Clinical Trials Network 121
Key Trial Info
Start Date :
October 10 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05208697
Start Date
October 10 2022
End Date
April 30 2026
Last Update
March 10 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Care Resource The SPOT
Fort Lauderdale, Florida, United States, 33311
2
University of Miami
Miami, Florida, United States, 33136
3
University of South Florida
Tampa, Florida, United States, 33612